In addition, more advanced PTC expressed elevated PD-L1 mRNA compared with less advanced tumors, suggesting PD-L1 may represent a useful target in thyroid cancer checkpoint inhibition. The gene discussed is CD274; the disease is thyroid gland carcinoma.